Neurovascular Device Market Outlook from 2024 to 2034

In the latest report by Future Market Insights, the lead research consultant estimates the global Neurovascular Device market value to reach US$ 3.0 billion in 2024.

The upward trajectory will continue securing growth, with projections indicating a market value of US$ 3.9 billion by 2034. This equates to a moderate CAGR of 2.7% through the forecast period.

Attributes Key Insights
Neurovascular Device Market Estimated Size in 2024 US$ 3.0 billion
Projected Market Value in 2034 US$ 3.9 billion
Value-based CAGR from 2024 to 2034 2.7%

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Market Trends and Highlights

  • Surging incidence of neurovascular is a factor that will pave the way for market during the forecast period.
  • Increasing technological advancements in neurovascular devices, is pacing up the market prospects.
  • Growing demand for minimally invasive procedures, is among the factors that is advancing swiftly towards market expansion.
  • Rising awareness as well as screening programs is also gaining momentum to propel the market.

2019 to 2023 Historical Analysis vs. 2024 to 2034 Market Forecast Projections

The scope for neurovascular device rose at a 5.1% CAGR between 2019 and 2023. The global market is achieving heights to grow at a moderate CAGR of 2.7% over the forecast period 2024 to 2034. Several advancements were made in the neurovascular equipment category, during the historical period, such as the creation of new stent designs, embolization techniques as well as imaging technologies.

Increasing prevalence of neurovascular diseases including stroke, aneurysms, and AVMs across the globe also contributed to the increasing demand for neurovascular devices. Patients as well as the healthcare providers shifted their preference towards the minimally invasive procedures as compared to traditional surgeries, owing to their low risks implications, shorter recovery periods and better diagnostic advantages.

Healthcare spending is projected is all set to climb up particularly in developing countries in the coming years. The increased investment will augment the demand for neurovascular devices and drive market expansion.

Regulatory reforms aimed at streamlining the approval process for medical devices and ensuring patient safety will facilitate market access for neurovascular device manufacturers.

Faster regulatory approvals and expanded reimbursement coverage will drive market growth and innovation. Advances in genomics, proteomics, as well as imaging technologies will accelerate the adoption of personalized medicine approaches in neurovascular care. Neurovascular devices tailored to individual patient characteristics and disease profiles will become increasingly important, leading to market growth.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Neurovascular Device Market Key Drivers

  • Expanding geriatric population will create the lucrative opportunities for the neurovascular device market.
  • Strategic collaborations and partnerships scale up the demand for neurovascular device.
  • Favorable reimbursement policies, are accelerating the demand for neurovascular device.
  • Focus on patient outcomes and quality of life is a major factor that is paving the way for market growth.

Challenges in the Neurovascular Device Market

  • High cost of neurovascular procedures is resulting in the downfall of the market.
  • Stringent regulatory requirements, is another factor that is causing a reduction in the viability of the market.
  • One of the major market restraining factors includes the risk of complications as well as adverse events.
  • Limited access to advanced healthcare facilities, can be a challenge, showing red signs to the market.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Comparative View of Adjacent Industries

Future Market Insights has compared two other industries, neurointerventional device market, and neuro immunoassay market. Increase in research and development investments is accelerating the market growth.

Rising incidence of neurological disorders is a major factor propelling the growth of market. The continually rising incidence of neurological diseases is augmenting stimulating the market growth.

Neurovascular Device Market:

Attributes Neurovascular Device Market
CAGR from 2024 to 2034 2.7%
Key Trends
  • Telemedicine and remote monitoring, is a major factor scaling up the market growth.
  • Personalized medicine and precision therapy, is paving the way for the market growth.
Opportunity
  • Shift towards value based healthcare is creating lucrative avenues for the market prospects.
  • Regulatory reforms and product approvals, is pacing up the demand for neurovascular device.

Neurointerventional Device Market:

Attributes Neurointerventional Device Market
CAGR from 2023 to 2033 4.7%
Key Trends
  • Increasing awareness and education is one of the major factors accelerating the market growth.
  • Expanding geriatric population is a major factor that is advancing the market growth.
Opportunity
  • Growing preference for minimally invasive procedures lead to the increased demand for neurointerventional devices.
  • Continuous advancements in neurointerventional devices, is a major factor propelling the market growth.

Neuro Immunoassay Market:

Attributes Neuro Immunoassay Market
CAGR from 2023 to 2033 7.3%
Key Trends
  • Growing emphasis on biomarker research is a major factor, leading to a surging market growth.
  • Advancements in immunoassay technologies is augmenting the market growth.
Opportunity
  • Increasing research funding and collaboration is a major factor that is creating lucrative opportunities for the market growth.
  • Rising demand for personalized medicine, is a major factor that is creating increased demand for neuro immunoassay.

Country-wise Insights

The below table showcases revenues in terms of the top 5 leading countries, spearheaded by India and Thailand. The countries will lead the market through 2034.

Countries Forecast CAGRs from 2024 to 2034
The United States 1.4%
Germany 2.2%
France 3.3%
Thailand 3.4%
India 5.5%

Technological Advancements Paving the Way for the Market in the United States

The neurovascular device market in the United States will expand at a CAGR of 1.4% through 2034. The country is a hub for medical innovation, with ongoing advancements in neurovascular devices such as stents, embolic coils, thrombectomy devices, and flow diverters.

The technological innovations improve the efficacy, safety, and outcomes of neurovascular interventions, augmenting the market growth. The United States has a significant burden of neurovascular diseases such as stroke, aneurysms, and arteriovenous malformations.

There is a growing demand for neurovascular devices to treat and manage these diseases, with an aging population and changing lifestyles contributing to the rise in these conditions.

Government Initiatives and Funding to Ride the Waves in in the United Kingdom

The neurovascular device market in the United Kingdom to expand at a CAGR of 2.2% through 2034. Government initiatives aimed at improving stroke care and reducing the burden of neurovascular diseases contribute to market growth.

Funding for stroke prevention programs, research grants, and investments in healthcare infrastructure further bolster the neurovascular device market in the country.

The United Kingdom has a well-developed healthcare infrastructure, including advanced hospitals, specialized neurovascular centers, and skilled healthcare professionals. The infrastructure supports the diagnosis, treatment, and management of neurovascular diseases, creating a conducive environment for market growth.

Increasing Aging Population Heads toward Success in France

Neurovascular device trends in France are taking a turn for the better. A 3.3% CAGR is forecast for the country from 2024 to 2034. France has an aging population, which is more susceptible to neurovascular diseases.

The growing elderly population increases the demand for neurovascular interventions and devices to manage conditions such as stroke and cerebral aneurysms.

Public awareness campaigns and educational programs raise awareness about the signs, symptoms, and risk factors associated with neurovascular diseases. Increased awareness leads to earlier diagnosis and treatment, driving the demand for neurovascular devices in France.

Medical Tourism Raises the Market Expansion in Thailand

The neurovascular device market in Thailand is poised to expand at a CAGR of 3.4% through 2034. Thailand has emerged as a popular destination for medical tourism due to its high quality healthcare services, affordable costs, and well trained medical professionals.

The influx of medical tourists seeking neurovascular treatments creates additional demand for neurovascular devices and procedures, accelerating the market growth. Increasing healthcare expenditure, both public and private in Thailand, reflects the growing investment in healthcare infrastructure, technology, and services.

The higher healthcare spending contributes to the expansion of neurovascular services and the adoption of advanced medical devices, including neurovascular devices.

Expanding Health Insurance Coverage to Enhance Prospects in India

The neurovascular device market in India will expand at a CAGR of 5.5% through 2034. The expansion of health insurance coverage in India, both through government schemes and private insurance providers, improves access to healthcare services for a larger segment of the population.

The affordability of neurovascular treatments increases, with more people covered by health insurance, stimulating market growth for neurovascular devices. India is increasingly becoming a hub for medical research and innovation, with the government and private sector investing in research and development initiatives.

The development of indigenous neurovascular devices, as well as collaborative research projects with international partners, leads to the introduction of innovative products tailored to the Indian market, stimulating market growth.

Category-wise Insights

The below table highlights how aneurysm coiling and embolization segment is leading the market in terms of product type, and will account for a share of 31.7% in 2024.

Based on disease pathology, the cerebral aneuryms segment is gaining heights and will to account for a share of 26.9% in 2024.

Category Shares in 2024
Aneurysm Coiling and Embolization 31.7%
Cerebral Aneuryms 26.9%

Aneurysm Coiling and Embolization Witnesses High Demand for Neurovascular Device

Based on product type, the aneurysm coiling and embolization segment will dominate the neurovascular device market. Aneurysms, particularly intracranial aneurysms, are a significant health concern globally.

The growing incidence of aneurysms, coupled with advancements in imaging technologies leading to better detection rates, is propelling the demand for aneurysm coiling and embolization devices. Aneurysm coiling and embolization procedures offer minimally invasive alternatives to traditional surgical treatments for aneurysms.

Patients and healthcare providers increasingly prefer these less invasive procedures due to their lower risk of complications, shorter recovery times, and better outcomes, thus boosting the demand for related devices.

Cerebral Aneuryms Segment to Hold High Demand for Neurovascular Device

In terms of disease pathology, the cerebral aneuryms segment will dominate the neurovascular device market. Technological advancements in aneurysm coiling and embolization devices have significantly improved treatment outcomes for cerebral aneurysms.

Innovations such as detachable coils, flow diverters, and intrasaccular devices offer more effective and minimally invasive options for managing cerebral aneurysms, thereby driving segmental growth.

Cerebral aneurysms are a common and serious neurovascular condition, with a significant proportion of cases leading to potentially life threatening complications such as subarachnoid hemorrhage. The increasing incidence of cerebral aneurysms globally is a primary driver for the growth of this segment.

Competitive Landscape

The neurovascular device market is characterized by intense competition among key players striving to maintain or enhance their market share through strategic initiatives, product innovation, and differentiation strategies.

Company Portfolio

  • Medtronic offers a comprehensive range of neurovascular devices including stents, embolic coils, thrombectomy devices, flow diverters, and neurovascular catheters. Their products are designed to address various neurovascular conditions such as stroke, cerebral aneurysms, and arteriovenous malformations.
  • Penumbra specializes in neurovascular and peripheral vascular devices for the treatment of stroke, cerebral aneurysms, and other vascular diseases. Their portfolio includes aspiration systems, thrombectomy devices, embolization coils, and flow diverters.

Key Coverage in the Neurovascular Device Industry Report

  • Neurovascular interventions
  • Endovascular therapy
  • Stroke treatment devices
  • Cerebral aneurysm management
  • Intracranial stents
  • Embolic coil systems
  • Thrombectomy devices
  • Intracranial hemorrhage management
  • Interventional Neurology Market
  • Neurointerventional Radiology Market
  • Neurosurgery Devices Market
  • Interventional Cardiology Market
  • Vascular Closure Devices Market
  • Neurostimulation Devices Market

Report Scope

Attribute Details
Estimated Market Size in 2024 US$ 3.0 billion
Projected Market Valuation in 2034 US$ 3.9 billion
Value-based CAGR 2024 to 2034 2.7%
Forecast Period 2024 to 2034
Historical Data Available for 2019 to 2023
Market Analysis Value in US$ Billion
Key Regions Covered
  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • South Asia and Pacific
  • East Asia
  • The Middle East & Africa
Key Market Segments Covered
  • Product
  • Disease Pathology
  • End User
  • Region
Key Countries Profiled
  • The United States
  • Canada
  • Brazil
  • Mexico
  • Germany
  • France
  • France
  • Spain
  • Italy
  • Russia
  • Poland
  • Czech Republic
  • Romania
  • India
  • Bangladesh
  • Australia
  • New Zealand
  • China
  • Japan
  • South Korea
  • GCC countries
  • South Africa
  • Israel
Key Companies Profiled
  • Medtronic
  • Penumbra, Inc.
  • Stryker
  • Johnson and Johnson Services, Inc.
  • MicroPort Scientific Corporation
  • Acandis GmbH
  • MicroVention, Inc.
  • NeuroVasc Technologies, Inc.
  • Asahi Intecc USA, Inc.
  • Perflow Medical Ltd.

Segmentation Analysis of the Neurovascular Device Market

By Product:

  • Aneurysm Coiling and Embolization Devices
  • Cerebral Balloon Angioplasty
  • Stentiny Systems
  • Support Devices
  • Neurothrombectomy Devices

By Disease Pathology:

  • Ischemic Strokes
  • Cerebral Aneuryms
  • Cartotid Artery Stenosis
  • Arteriovenous Malformations
  • Fistulas
  • Others

By End User:

  • Hospitals and Surgical Centers
  • Ambulatory Care Centers
  • Research Laboratories
  • Academic Institutes

By Region:

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • South Asia and Pacific
  • East Asia
  • The Middle East and Africa

Frequently Asked Questions

What is the anticipated value of the Neurovascular Device market in 2024?

The neurovascular device market is projected to reach a valuation of US$ 3.0 billion in 2024.

What is the expected CAGR for the Neurovascular Device market until 2034?

The neurovascular device industry is set to expand by a CAGR of 2.7% through 2034.

How much valuation is projected for the Neurovascular Device market in 2034?

The neurovascular device market is forecast to reach US$ 3.9 billion by 2034.

Which country is projected to lead the Neurovascular Device market?

India is set to be the top performing market, exhibiting a CAGR of 5.5% through 2034.

Which is the dominant product type in the Neurovascular Device domain?

Aneurysm coiling and embolization devices segment is preferred, and will hold the major share of 33.2% through 2024.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Product Life Cycle Analysis

    3.5. Supply Chain Analysis

        3.5.1. Supply Side Participants and their Roles

            3.5.1.1. Manufacturer

        3.5.2. Value Added and Value Created at Node in the Supply Chain

        3.5.3. List of Raw Material Suppliers

        3.5.4. List of Existing and Potential Buyer’s

    3.6. Investment Feasibility Matrix

    3.7. Value Chain Analysis

        3.7.1. Profit Margin Analysis

    3.8. PESTLE and Porter’s Analysis

    3.9. Regulatory Landscape

        3.9.1. By Key Regions

        3.9.2. By Key Countries

    3.10. Regional Parent Market Outlook

    3.11. Production and Consumption Statistics

    3.12. Import and Export Statistics

4. Global Market Analysis 2019 to 2023 and Forecast, 2024 to 2034

    4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2019 to 2023

    4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2024 to 2034

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Device

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Device, 2019 to 2023

    5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Device, 2024 to 2034

        5.3.1. Cerebral Embolization and Aneurysm Coiling Devices

            5.3.1.1. Embolic Coils

            5.3.1.2. Flow Diversion Devices

            5.3.1.3. Liquid Embolic Agents

        5.3.2. Cerebral Angioplasty and Stenting Systems

            5.3.2.1. Carotid Artery Stents

            5.3.2.2. Embolic Protection

        5.3.3. Neurothrombectomy Devices

            5.3.3.1. Clot Retrieval Devices

            5.3.3.2. Suction Devices/Aspiration Catheters

            5.3.3.3. Vascular Snares

        5.3.4. Support Devices

            5.3.4.1. Micro Catheters

            5.3.4.2. Micro Guidewires

        5.3.5. Trans Radial Access Devices

    5.4. Y-o-Y Growth Trend Analysis By Device, 2019 to 2023

    5.5. Absolute $ Opportunity Analysis By Device, 2024 to 2034

6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Disease Pathology

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Disease Pathology, 2019 to 2023

    6.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Disease Pathology, 2024 to 2034

        6.3.1. Ischemic Strokes

        6.3.2. Cerebral Aneurysm

        6.3.3. Carotid Artery Stenosis

        6.3.4. Arteriovenous Malformations

        6.3.5. Fistulas

        6.3.6. Others

    6.4. Y-o-Y Growth Trend Analysis By Disease Pathology, 2019 to 2023

    6.5. Absolute $ Opportunity Analysis By Disease Pathology, 2024 to 2034

7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By End-User

    7.1. Introduction / Key Findings

    7.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By End-User, 2019 to 2023

    7.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By End-User, 2024 to 2034

        7.3.1. Hospitals & Surgical Centres

        7.3.2. Ambulatory Care Centres

        7.3.3. Research Laboratories

        7.3.4. Academic Institutes

    7.4. Y-o-Y Growth Trend Analysis By End-User, 2019 to 2023

    7.5. Absolute $ Opportunity Analysis By End-User, 2024 to 2034

8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region

    8.1. Introduction

    8.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Region, 2019 to 2023

    8.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Region, 2024 to 2034

        8.3.1. North America

        8.3.2. Latin America

        8.3.3. Western Europe

        8.3.4. Eastern Europe

        8.3.5. South Asia and Pacific

        8.3.6. East Asia

        8.3.7. Middle East and Africa

    8.4. Market Attractiveness Analysis By Region

9. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

    9.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023

    9.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034

        9.2.1. By Country

            9.2.1.1. USA

            9.2.1.2. Canada

        9.2.2. By Device

        9.2.3. By Disease Pathology

        9.2.4. By End-User

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Device

        9.3.3. By Disease Pathology

        9.3.4. By End-User

    9.4. Key Takeaways

10. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

    10.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023

    10.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034

        10.2.1. By Country

            10.2.1.1. Brazil

            10.2.1.2. Mexico

            10.2.1.3. Rest of Latin America

        10.2.2. By Device

        10.2.3. By Disease Pathology

        10.2.4. By End-User

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Device

        10.3.3. By Disease Pathology

        10.3.4. By End-User

    10.4. Key Takeaways

11. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

    11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023

    11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034

        11.2.1. By Country

            11.2.1.1. Germany

            11.2.1.2. UK

            11.2.1.3. France

            11.2.1.4. Spain

            11.2.1.5. Italy

            11.2.1.6. Rest of Western Europe

        11.2.2. By Device

        11.2.3. By Disease Pathology

        11.2.4. By End-User

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Device

        11.3.3. By Disease Pathology

        11.3.4. By End-User

    11.4. Key Takeaways

12. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

    12.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023

    12.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034

        12.2.1. By Country

            12.2.1.1. Poland

            12.2.1.2. Russia

            12.2.1.3. Czech Republic

            12.2.1.4. Romania

            12.2.1.5. Rest of Eastern Europe

        12.2.2. By Device

        12.2.3. By Disease Pathology

        12.2.4. By End-User

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Device

        12.3.3. By Disease Pathology

        12.3.4. By End-User

    12.4. Key Takeaways

13. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

    13.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023

    13.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034

        13.2.1. By Country

            13.2.1.1. India

            13.2.1.2. Bangladesh

            13.2.1.3. Australia

            13.2.1.4. New Zealand

            13.2.1.5. Rest of South Asia and Pacific

        13.2.2. By Device

        13.2.3. By Disease Pathology

        13.2.4. By End-User

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Device

        13.3.3. By Disease Pathology

        13.3.4. By End-User

    13.4. Key Takeaways

14. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

    14.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023

    14.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034

        14.2.1. By Country

            14.2.1.1. China

            14.2.1.2. Japan

            14.2.1.3. South Korea

        14.2.2. By Device

        14.2.3. By Disease Pathology

        14.2.4. By End-User

    14.3. Market Attractiveness Analysis

        14.3.1. By Country

        14.3.2. By Device

        14.3.3. By Disease Pathology

        14.3.4. By End-User

    14.4. Key Takeaways

15. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

    15.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023

    15.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034

        15.2.1. By Country

            15.2.1.1. GCC Countries

            15.2.1.2. South Africa

            15.2.1.3. Israel

            15.2.1.4. Rest of MEA

        15.2.2. By Device

        15.2.3. By Disease Pathology

        15.2.4. By End-User

    15.3. Market Attractiveness Analysis

        15.3.1. By Country

        15.3.2. By Device

        15.3.3. By Disease Pathology

        15.3.4. By End-User

    15.4. Key Takeaways

16. Key Countries Market Analysis

    16.1. USA

        16.1.1. Pricing Analysis

        16.1.2. Market Share Analysis, 2023

            16.1.2.1. By Device

            16.1.2.2. By Disease Pathology

            16.1.2.3. By End-User

    16.2. Canada

        16.2.1. Pricing Analysis

        16.2.2. Market Share Analysis, 2023

            16.2.2.1. By Device

            16.2.2.2. By Disease Pathology

            16.2.2.3. By End-User

    16.3. Brazil

        16.3.1. Pricing Analysis

        16.3.2. Market Share Analysis, 2023

            16.3.2.1. By Device

            16.3.2.2. By Disease Pathology

            16.3.2.3. By End-User

    16.4. Mexico

        16.4.1. Pricing Analysis

        16.4.2. Market Share Analysis, 2023

            16.4.2.1. By Device

            16.4.2.2. By Disease Pathology

            16.4.2.3. By End-User

    16.5. Germany

        16.5.1. Pricing Analysis

        16.5.2. Market Share Analysis, 2023

            16.5.2.1. By Device

            16.5.2.2. By Disease Pathology

            16.5.2.3. By End-User

    16.6. UK

        16.6.1. Pricing Analysis

        16.6.2. Market Share Analysis, 2023

            16.6.2.1. By Device

            16.6.2.2. By Disease Pathology

            16.6.2.3. By End-User

    16.7. France

        16.7.1. Pricing Analysis

        16.7.2. Market Share Analysis, 2023

            16.7.2.1. By Device

            16.7.2.2. By Disease Pathology

            16.7.2.3. By End-User

    16.8. Spain

        16.8.1. Pricing Analysis

        16.8.2. Market Share Analysis, 2023

            16.8.2.1. By Device

            16.8.2.2. By Disease Pathology

            16.8.2.3. By End-User

    16.9. Italy

        16.9.1. Pricing Analysis

        16.9.2. Market Share Analysis, 2023

            16.9.2.1. By Device

            16.9.2.2. By Disease Pathology

            16.9.2.3. By End-User

    16.10. Poland

        16.10.1. Pricing Analysis

        16.10.2. Market Share Analysis, 2023

            16.10.2.1. By Device

            16.10.2.2. By Disease Pathology

            16.10.2.3. By End-User

    16.11. Russia

        16.11.1. Pricing Analysis

        16.11.2. Market Share Analysis, 2023

            16.11.2.1. By Device

            16.11.2.2. By Disease Pathology

            16.11.2.3. By End-User

    16.12. Czech Republic

        16.12.1. Pricing Analysis

        16.12.2. Market Share Analysis, 2023

            16.12.2.1. By Device

            16.12.2.2. By Disease Pathology

            16.12.2.3. By End-User

    16.13. Romania

        16.13.1. Pricing Analysis

        16.13.2. Market Share Analysis, 2023

            16.13.2.1. By Device

            16.13.2.2. By Disease Pathology

            16.13.2.3. By End-User

    16.14. India

        16.14.1. Pricing Analysis

        16.14.2. Market Share Analysis, 2023

            16.14.2.1. By Device

            16.14.2.2. By Disease Pathology

            16.14.2.3. By End-User

    16.15. Bangladesh

        16.15.1. Pricing Analysis

        16.15.2. Market Share Analysis, 2023

            16.15.2.1. By Device

            16.15.2.2. By Disease Pathology

            16.15.2.3. By End-User

    16.16. Australia

        16.16.1. Pricing Analysis

        16.16.2. Market Share Analysis, 2023

            16.16.2.1. By Device

            16.16.2.2. By Disease Pathology

            16.16.2.3. By End-User

    16.17. New Zealand

        16.17.1. Pricing Analysis

        16.17.2. Market Share Analysis, 2023

            16.17.2.1. By Device

            16.17.2.2. By Disease Pathology

            16.17.2.3. By End-User

    16.18. China

        16.18.1. Pricing Analysis

        16.18.2. Market Share Analysis, 2023

            16.18.2.1. By Device

            16.18.2.2. By Disease Pathology

            16.18.2.3. By End-User

    16.19. Japan

        16.19.1. Pricing Analysis

        16.19.2. Market Share Analysis, 2023

            16.19.2.1. By Device

            16.19.2.2. By Disease Pathology

            16.19.2.3. By End-User

    16.20. South Korea

        16.20.1. Pricing Analysis

        16.20.2. Market Share Analysis, 2023

            16.20.2.1. By Device

            16.20.2.2. By Disease Pathology

            16.20.2.3. By End-User

    16.21. GCC Countries

        16.21.1. Pricing Analysis

        16.21.2. Market Share Analysis, 2023

            16.21.2.1. By Device

            16.21.2.2. By Disease Pathology

            16.21.2.3. By End-User

    16.22. South Africa

        16.22.1. Pricing Analysis

        16.22.2. Market Share Analysis, 2023

            16.22.2.1. By Device

            16.22.2.2. By Disease Pathology

            16.22.2.3. By End-User

    16.23. Israel

        16.23.1. Pricing Analysis

        16.23.2. Market Share Analysis, 2023

            16.23.2.1. By Device

            16.23.2.2. By Disease Pathology

            16.23.2.3. By End-User

17. Market Structure Analysis

    17.1. Competition Dashboard

    17.2. Competition Benchmarking

    17.3. Market Share Analysis of Top Players

        17.3.1. By Regional

        17.3.2. By Device

        17.3.3. By Disease Pathology

        17.3.4. By End-User

18. Competition Analysis

    18.1. Competition Deep Dive

        18.1.1. Medtronic

            18.1.1.1. Overview

            18.1.1.2. Product Portfolio

            18.1.1.3. Profitability by Market Segments

            18.1.1.4. Sales Footprint

            18.1.1.5. Strategy Overview

                18.1.1.5.1. Marketing Strategy

                18.1.1.5.2. Product Strategy

                18.1.1.5.3. Channel Strategy

        18.1.2. Penumbra, Inc.

            18.1.2.1. Overview

            18.1.2.2. Product Portfolio

            18.1.2.3. Profitability by Market Segments

            18.1.2.4. Sales Footprint

            18.1.2.5. Strategy Overview

                18.1.2.5.1. Marketing Strategy

                18.1.2.5.2. Product Strategy

                18.1.2.5.3. Channel Strategy

        18.1.3. Stryker

            18.1.3.1. Overview

            18.1.3.2. Product Portfolio

            18.1.3.3. Profitability by Market Segments

            18.1.3.4. Sales Footprint

            18.1.3.5. Strategy Overview

                18.1.3.5.1. Marketing Strategy

                18.1.3.5.2. Product Strategy

                18.1.3.5.3. Channel Strategy

        18.1.4. Johnson and Johnson Services, Inc.

            18.1.4.1. Overview

            18.1.4.2. Product Portfolio

            18.1.4.3. Profitability by Market Segments

            18.1.4.4. Sales Footprint

            18.1.4.5. Strategy Overview

                18.1.4.5.1. Marketing Strategy

                18.1.4.5.2. Product Strategy

                18.1.4.5.3. Channel Strategy

        18.1.5. MicroPort Scientific Corporation

            18.1.5.1. Overview

            18.1.5.2. Product Portfolio

            18.1.5.3. Profitability by Market Segments

            18.1.5.4. Sales Footprint

            18.1.5.5. Strategy Overview

                18.1.5.5.1. Marketing Strategy

                18.1.5.5.2. Product Strategy

                18.1.5.5.3. Channel Strategy

        18.1.6. Acandis GmbH

            18.1.6.1. Overview

            18.1.6.2. Product Portfolio

            18.1.6.3. Profitability by Market Segments

            18.1.6.4. Sales Footprint

            18.1.6.5. Strategy Overview

                18.1.6.5.1. Marketing Strategy

                18.1.6.5.2. Product Strategy

                18.1.6.5.3. Channel Strategy

        18.1.7. MicroVention, Inc.

            18.1.7.1. Overview

            18.1.7.2. Product Portfolio

            18.1.7.3. Profitability by Market Segments

            18.1.7.4. Sales Footprint

            18.1.7.5. Strategy Overview

                18.1.7.5.1. Marketing Strategy

                18.1.7.5.2. Product Strategy

                18.1.7.5.3. Channel Strategy

        18.1.8. NeuroVasc Technologies, Inc.

            18.1.8.1. Overview

            18.1.8.2. Product Portfolio

            18.1.8.3. Profitability by Market Segments

            18.1.8.4. Sales Footprint

            18.1.8.5. Strategy Overview

                18.1.8.5.1. Marketing Strategy

                18.1.8.5.2. Product Strategy

                18.1.8.5.3. Channel Strategy

        18.1.9. Asahi Intecc USA, Inc.

            18.1.9.1. Overview

            18.1.9.2. Product Portfolio

            18.1.9.3. Profitability by Market Segments

            18.1.9.4. Sales Footprint

            18.1.9.5. Strategy Overview

                18.1.9.5.1. Marketing Strategy

                18.1.9.5.2. Product Strategy

                18.1.9.5.3. Channel Strategy

        18.1.10. Perflow Medical Ltd.

            18.1.10.1. Overview

            18.1.10.2. Product Portfolio

            18.1.10.3. Profitability by Market Segments

            18.1.10.4. Sales Footprint

            18.1.10.5. Strategy Overview

                18.1.10.5.1. Marketing Strategy

                18.1.10.5.2. Product Strategy

                18.1.10.5.3. Channel Strategy

19. Assumptions & Acronyms Used

20. Research Methodology

Recommendations

Healthcare

Neurodegenerative Disease Market

March 2022

REP-GB-1052

May 2024

250 pages

Healthcare

Neurointerventional Device Market

August 2020

REP-GB-871

October 2023

223 pages

Healthcare

Neuro Immunoassay Market

July 2017

REP-GB-4293

July 2023

306 pages

Healthcare

Neurotrophic Keratitis Treatment Market

April 2023

REP-GB-17006

April 2023

299 pages

Explore Healthcare Insights

View Reports
Future Market Insights

Neurovascular Device Market